Patents-Review.com
ClassID:

20091 ⎘

A61K9/167 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Sub-classes:
Recent Application in this class:
#1
20260076936
2026-03-19

SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION OF SIVELESTAT OR SALT THEREOF AND PREPARATION METHOD THEREOF

 #2
20260076920
2026-03-19

VIRUS-LIKE PARTICLES FOR PREVENTING THE SPREADING AND LOWERING THE INFECTION RATE OF VIRUSES

 #3
20260041786
2026-02-12

MINERAL COATED MICROPARTICLES FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES

 #4
20260027055
2026-01-29

METHOD FOR PRODUCING GRANULES CONTAINING A CORE PARTICLE, GRANULES CONTAINING A CORE PARTICLE, PHARMACEUTICAL COMPOSITION CONTAINING THE GRANULES CONTAINING THE CORE PARTICLE, AND PREPARATION CONTAINING THE PHARMACEUTICAL COMPOSITION

 #5
20250319030
2025-10-16

CENTANAFADINE PHARMACEUTICAL FORMULATIONS, AND METHODS OF MAKING AND USING SAME

 #6
20250281428
2025-09-11

Method Of Treating Major Depressive Disorder

 #7
20250275988
2025-09-04

FORMULATION FOR TREATING URINARY SYSTEM DISORDERS

 #8
20250249133
2025-08-07

RADIOEMBOLIC BEADS AND METHODS FOR TREATMENT OF TUMOR CELLS

 #9
20250221938
2025-07-10

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

 #10
20250213498
2025-07-03

METHODS OF TARGETED DELIVERY TO A HOST USING A CARRIER

 #11
20250213483
2025-07-03

REDUCING THE ENVIRONMENTAL IMPACT OF FARMING USING BIOCHAR

 #12
20250205160
2025-06-26

STABLE PHARMACEUTICAL COMPOSITION OF AN AMINE DRUG

 #13
20250195454
2025-06-19

METHOD OF TREATING MAJOR DEPRESSIVE DISORDER

 #14
20250177320
2025-06-05

PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL

 #15
20250144111
2025-05-08

TAUROLIDINE TREATMENT FOR MYC-EXPRESSING TUMORS IN MAMMALIAN BODIES

 #16
20250127752
2025-04-24

REDUCED REBOUND EFFECTS IN SUBJECTS TREATED FOR OVERWEIGHT OR OBESITY

 #17
20250108014
2025-04-03

CARRIER FOR LOWERING THE INFECTION RATE OF BACTERIA

 #18
20250057782
2025-02-20

Methods of fabricating carriers for targeted delivery to a host

 #19
20250049753
2025-02-13

METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS

 #20
20250049719
2025-02-13

DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF

 #21
20250041225
2025-02-06

CENTANAFADINE PHARMACEUTICAL FORMULATIONS, AND METHODS OF MAKING AND USING SAME

 #22
20250017869
2025-01-16

PARTICLE-BASED MULTI-LAYER THERAPEUTIC DELIVERY DEVICE AND METHOD

 #23
20240398753
2024-12-05

METHOD FOR PRODUCING LIQUID MIXTURE, LIQUID MIXTURE, AND SOLID COMPOSITION

 #24
20240382421
2024-11-21

WATER SOLUBLE COMPOSITIONS AND METHODS OF MAKING THE SAME

 #25
20240350479
2024-10-24

Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response

 #26
20240299343
2024-09-12

METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS

 #27
20240226012
2024-07-11

NOVEL MULTIVALENT NANOPARTICLE-BASED VACCINES

 #28
20240226011
2024-07-11

CORE-SHELL MICELLE MICROSPHERE, AND PREPARATION METHOD THEREFOR AND USE THEREOF

 #29
20240189333
2024-06-13

PHOSPHOLIPID COMPOUNDS AND FORMULATIONS

 #30
20240180838
2024-06-06

NANOPARTICLE (NP) COMPOSITIONS AND METHODS OF USE THEREOF

 #31
20240165030
2024-05-23

Centanafadine pharmaceutical formulations, and methods of making and using same

 #32
20240158421
2024-05-16

NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS

 #33
20240156746
2024-05-16

Carrier for targeted delivery to a host

 #34
20240148758
2024-05-09

CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES

 #35
20240115506
2024-04-11

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

 #36
20240091174
2024-03-21

Method Of Treating Major Depressive Disorder

 #37
20240074992
2024-03-07

Method Of Treating Major Depressive Disorder

 #38
20240074991
2024-03-07

Method of treating major depressive disorder

 #39
20240058296
2024-02-22

MODIFIED ANTIBODY-ALBUMIN NANOPARTICLE COMPLEXES FOR CANCER TREATMENT

 #40
20240041893
2024-02-08

An Extended-Release Pharmaceutical Formulation of Viloxazine And Process For Preparation Thereof

 #41
20230414656
2023-12-28

SYSTEMS AND METHODS FOR REPAIRING SPINAL DISC INJURY OR TREATING SPINAL DISC DISEASE

 #42
20230398077
2023-12-14

SILICASOME NANOCARRIER FOR METAL-BASED DRUG DELIVERY

 #43
20230390206
2023-12-07

METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES

 #44
20230390205
2023-12-07

MINIMIZING AGGLOMERATION OF DRUG PARTICLE COATING MATERIAL DURING STORAGE TO STABILIZE DISINTEGRATION TIMES OF PHARMACEUTICAL PRODUCTS

 #45
20230381268
2023-11-30

Granular Pharmaceutical Composition

 #46
20230338481
2023-10-26

DIGESTIVE ENZYME COMPOSITION SUITABLE FOR ENTERAL ADMINISTRATION

 #47
20230338293
2023-10-26

Centanafadine pharmaceutical formulations, and methods of making and using same

 #48
20230310329
2023-10-05

Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

 #49
20230309595
2023-10-05

DIETARY SUPPLEMENT COMPOSITIONS COMPRISING GANODERMA AND METHODS FOR MAKING

 #50
20230293438
2023-09-21

INJECTABLE DRUG-RELEASING MICROPOROUS ANNEALED PARTICLE SCAFFOLDS FOR TREATING MYOCARDIAL INFARCTION

 #51
20230270680
2023-08-31

BIOACTIVATABLE DEVICES AND RELATED METHODS

 #52
20230240994
2023-08-03

MEDICAMENT-CONTAINING HOLLOW PARTICLE

 #53
20230233487
2023-07-27

Method of treating major depressive disorder

 #54
20230218547
2023-07-13

CHEMICAL COMPOSITION

 #55
20230172871
2023-06-08

Virus-like particles for preventing the spreading and lowering the infection rate of viruses

 #56
20230158008
2023-05-25

METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS

 #57
20230157956
2023-05-25

Oral Drug Delivery System and Method for Fabricating Thereof

 #58
20230125341
2023-04-27

Reducing the environmental impact of farming using biochar

 #59
20230113303
2023-04-13

Granular Pharmaceutical Composition

 #60
20230104529
2023-04-06

Centanafadine pharmaceutical formulations, and methods of making and using same

 #61
20230083072
2023-03-16

FILM-COATED GRANULE, PHARMACEUTICAL PREPARATION CONTAINING THE SAME, AND MANUFACTURING METHODS THEREOF

 #62
20220409539
2022-12-29

PARTICLES FOR MULTI-DOSE DELIVERY

 #63
20220395517
2022-12-15

Method of treating urolithiasis

 #64
20220387458
2022-12-08

Methods of manufacturing microspheres

 #65
20220361530
2022-11-17

FEED INGREDIENTS COMPRISING LYSED MICROBIAL CELLS

 #66
20220347101
2022-11-03

ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE

 #67
20220331267
2022-10-20

METHODS AND COMPOSITIONS FOR TREATMENT OF DEMYELINATING DISORDERS

 #68
20220331246
2022-10-20

CONTROLLED RELEASE CORE-SHELL PARTICLES AND SUSPENSIONS INCLUDING THE SAME

 #69
20220323451
2022-10-13

Taurultam, taurinamide and methylene glycol treatment for MYC—expressing tumors in mammalian bodies

 #70
20220287968
2022-09-15

LIPID VESICLE-MEDIATED DELIVERY TO CELLS

 #71
20220280602
2022-09-08

ANTICANCER AGENT AND METHOD FOR PREPARATION OF POROUS SILICA PARTICLE

 #72
20220273581
2022-09-01

Virus-like particles for preventing the spreading and lowering the infection rate of viruses

 #73
20220265557
2022-08-25

Centanafadine pharmaceutical formulations, and methods of making and using same

 #74
20220257696
2022-08-18

Granular Pharmaceutical Composition

 #75
20220249585
2022-08-11

MEDICATION COATED WITH HEMP OR OTHER CANNABINOID

 #76
20220218902
2022-07-14

DEVICE AND METHOD FOR IMPROVING RETENTION OF A THERAPY IN THE BLADDER

 #77
20220211619
2022-07-07

Water soluble compositions and methods of making the same

 #78
20220168432
2022-06-02

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #79
20220152149
2022-05-19

Annexin-coated particles

 #80
20220133762
2022-05-05

Method of treating cancer with composition of traditional Chinese medicine and its preparation method thereof

 #81
20220125742
2022-04-28

Method of treating major depressive disorder

 #82
20220125734
2022-04-28

Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

 #83
20220110867
2022-04-14

METHODS AND SYSTEMS FOR FORMING MULTI-LAYERED PARTICLES

 #84
20220105200
2022-04-07

METHODS FOR PREVENTING AND TREATING INFLAMMATION AND INFLAMMATORY DISEASE

 #85
20220105064
2022-04-07

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #86
20220105043
2022-04-07

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

 #87
20220054419
2022-02-24

Multivalent nanoparticle-based vaccines

 #88
20220016041
2022-01-20

Once Daily Formulations Of Tetracyclines

 #89
20220008501
2022-01-13

Granular Pharmaceutical Composition

 #90
20210401826
2021-12-30

ABUSE DETERRENT PHARMACEUTICAL FORMULATIONS

 #91
20210379013
2021-12-09

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

 #92
20210353544
2021-11-18

METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF ACTIVE AGENTS FOR CRYSTALLINE MICROPARTICLE SURFACES

 #93
20210346478
2021-11-11

Nano-satellite complexes

 #94
20210338671
2021-11-04

COMPOSITIONS OF SURFACE-MODIFIED THERAPEUTICALLY ACTIVE PARTICLES BY ULTRA-RAPID FREEZING

 #95
20210290554
2021-09-23

Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration

 #96
20210283237
2021-09-16

VACCINE COMPOSITIONS

 #97
20210283229
2021-09-16

DIGESTIVE ENZYME COMPOSITION SUITABLE FOR ENTERAL ADMINISTRATION

 #98
20210275578
2021-09-09

Drug and production method therefor

 #99
20210275461
2021-09-09

PARTICLES FOR ADMINISTRATION OF ACTIVE INGREDIENTS AND METHODS OF MAKING THE SAME

 #100
20210267930
2021-09-02

MODIFIED ANTIBODY-ALBUMIN NANOPARTICLE COMPLEXES FOR CANCER TREATMENT

 #101
20210267899
2021-09-02

Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products

 #102
20210251904
2021-08-19

METHOD FOR PRODUCING GRANULES CONTAINING A CORE PARTICLE, GRANULES CONTAINING A CORE PARTICLE, PHARMACEUTICAL COMPOSITION CONTAINING THE GRANULES CONTAINING THE CORE PARTICLE, AND PREPARATION CONTAINING THE PHARMACEUTICAL COMPOSITION

 #103
20210236524
2021-08-05

Phospholipid compounds and formulations

 #104
20210236433
2021-08-05

Methods and systems for forming layered solid particles

 #105
20210236418
2021-08-05

Composition and method for oral treatment of leukemia

 #106
20210228505
2021-07-29

Method of treating major depressive disorder

 #107
20210220318
2021-07-22

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #108
20210205222
2021-07-08

DEXAMETHASONE PRODRUG COMPOSITIONS AND USES THEREOF

 #109
20210205221
2021-07-08

Microparticles containing dutasteride, and preparation method therefor

 #110
20210196888
2021-07-01

Device and method for improving retention of a therapy in the bladder

 #111
20210186885
2021-06-24

POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS

 #112
20210177873
2021-06-17

Anticancer composition of traditional Chinese medicine and preparation method thereof

 #113
20210169816
2021-06-10

Water soluble compositions and methods of making the same

 #114
20210162055
2021-06-03

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #115
20210161996
2021-06-03

Granular Pharmaceutical Composition

 #116
20210154139
2021-05-27

Controlled release core-shell particles and suspensions including the same

 #117
20210137790
2021-05-13

Method for the formulation of oil-soluble substances, and powders obtainable thereof

 #118
20210113542
2021-04-22

Methods and compositions for self-regulated release of active pharmaceutical ingredients

 #119
20210077411
2021-03-18

Methods and systems for forming multi-layered particles

 #120
20210077394
2021-03-18

Controlled release core-shell particles and suspensions including the same

 #121
20210069113
2021-03-11

SOLID UNIT DOSAGE FORM FOR DOSE INDIVIDUALIZED DRUG DELIVERY

 #122
20210059945
2021-03-04

Oral Drug Delivery System and Method for Fabricating Thereof

 #123
20210059944
2021-03-04

NOVEL DOSAGE FORM

 #124
20210052637
2021-02-25

Magnetic nanoparticles for use in the treatment of tumors

 #125
20210052507
2021-02-25

DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS

 #126
20210038734
2021-02-11

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #127
20210030667
2021-02-04

Ocular inserts comprising a covalently linked steroid dimer

 #128
20210015790
2021-01-21

Anti-methanogenic lovastatin analogs or derivatives and uses thereof

 #129
20200390794
2020-12-17

Targeted intracellular delivery of antiviral agents

 #130
20200390715
2020-12-17

Biodegradable Microcapsules Containing Filling Material

 #131
20200390704
2020-12-17

Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products

 #132
20200383972
2020-12-10

TEMOZOLOMIDE POWDER FORMULATION

 #133
20200375901
2020-12-03

Oral composition and methods for manufacturing the same and treatment

 #134
20200338008
2020-10-29

Coated Drug Compositions and Methods of Preparing the Same

 #135
20200323935
2020-10-15

NOVEL METHOD FOR THE TREATMENT OF DYSPEPSIA, FOOD AND MEDICINE INTOLERANCES, IRRITABLE BOWEL SYNDROME AND OTHER FUNCTIONAL GASTROINTESTINAL CONDITIONS

 #136
20200306189
2020-10-01

Lipid composition for improving body composition during catch-up growth

 #137
20200276202
2020-09-03

LAYERED SUSTAINED-RELEASE MICROBEADS AND METHODS OF MAKING THE SAME

 #138
20200268667
2020-08-27

Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products

 #139
20200206305
2020-07-02

Granular Pharmaceutical Composition

 #140
20200206136
2020-07-02

Cellulosic polymer nanoparticles and methods of forming them

 #141
20200197309
2020-06-25

METHODS AND COMPOSITIONS FOR THE TREATMENT OF RETINAL, NEUROLOGICAL AND OTHER RELATED DISEASES

 #142
20200188352
2020-06-18

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

 #143
20200179439
2020-06-11

Enteric coated silicon drug and production method therefor

 #144
20200164087
2020-05-28

MINERAL COATED MICROPARTICLES FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES

 #145
20200147005
2020-05-14

Method of treating major depressive disorder

 #146
20200121797
2020-04-23

Modified release formulations containing drug-ion exchange resin complexes

 #147
20200113834
2020-04-16

Dexamethasone prodrug compositions and uses thereof

 #148
20200113833
2020-04-16

Dexamethasone prodrug compositions and uses thereof

 #149
20200060989
2020-02-27

Quinic acid-modified nanoparticles and uses thereof

 #150
20200048105
2020-02-13

Substances containing AuCs and preparation method and use thereof

 #151
20200046758
2020-02-13

ORAL CHOLESTYRAMINE FORMULATION AND USE THEREOF

 #152
20200046757
2020-02-13

CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE FORMULATIONS, AND USES THEREOF

 #153
20200030285
2020-01-30

Methods and compositions for delivering mycophenolic acid active agents to non-human mammals

 #154
20200009258
2020-01-09

Lactuloside compounds and preparation and use thereof

 #155
20200009076
2020-01-09

PHARMACEUTICAL FORMULATIONS OF PHLOROGLUCINOL AND TRIMETHYLPHLOROGLUCINOL

 #156
20190381060
2019-12-19

TAUROLIDINE TREATMENT FOR MYC-EXPRESSING TUMORS IN MAMMALIAN BODIES

 #157
20190358221
2019-11-28

Opioid agonist / antagonist combination dosage forms

 #158
20190350897
2019-11-21

ESCALATING DOSING REGIMEN FOR EFFECTING WEIGHT LOSS AND TREATING OBESITY

 #159
20190343787
2019-11-14

Controlled release pharmaceutical compositions comprising a fumaric acid ester

 #160
20190328670
2019-10-31

Microparticles for Oral Delivery

 #161
20190321396
2019-10-24

Substances containing AuCs and preparation method and use thereof

 #162
20190321310
2019-10-24

CHEMICAL COMPOSITION

 #163
20190314289
2019-10-17

Pharmaceutical Compositions for the Deterrence and/or Prevention of Abuse

 #164
20190290586
2019-09-26

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

 #165
20190275167
2019-09-12

Glass formulations and uses thereof

 #166
20190274957
2019-09-12

BIODEGRADABLE MICROBEADS WITH IMPROVED ANTICANCER DRUG ADSORPTIVITY, CONTAINING ALBUMIN AND DEXTRAN SULFATE, AND PREPARATION METHOD THEREFOR

 #167
20190254976
2019-08-22

MEDICAMENT-CONTAINING HOLLOW PARTICLE

 #168
20190247311
2019-08-15

Dexamethasone prodrug compositions and uses thereof

 #169
20190216741
2019-07-18

Formulations of cysteamine and cysteamine derivatives

 #170
20190201375
2019-07-04

Methods and compositions for delivering mycophenolic acid active agents to non-human mammals

 #171
20190201368
2019-07-04

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #172
20190151460
2019-05-23

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #173
20190142952
2019-05-16

Modified release formulations containing drug-ion exchange resin complexes

 #174
20190142760
2019-05-16

Particle-based multi-layer therapeutic delivery device and method

 #175
20190125683
2019-05-02

Once Daily Formulations Of Tetracyclines

 #176
20190117613
2019-04-25

Controlled release pharmaceutical compositions comprising a fumaric acid ester

 #177
20190117574
2019-04-25

SURFACE-MODIFIED MICROSPHERE COMPOSITION, APPLICATION OF THE SAME, AND METHOD OF PREPARING THE SAME

 #178
20190111187
2019-04-18

Therapeutic nanoparticles for treating vascular diseases

 #179
20190091193
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #180
20190091192
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #181
20190091191
2019-03-28

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #182
20190076363
2019-03-14

Controlled release delivery device comprising an organosol coat

 #183
20190060395
2019-02-28

Granular Pharmaceutical Composition

 #184
20190060287
2019-02-28

TIZANIDINE FORMULATIONS

 #185
20190030069
2019-01-31

Application of substances containing AuCs in preparing medicine for preventing and treating Alzheimer's disease

 #186
20190029961
2019-01-31

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

 #187
20180369248
2018-12-27

Layered sustained-release microbeads and methods of making the same

 #188
20180360759
2018-12-20

Enzyme delivery systems and methods of preparation and use

 #189
20180353605
2018-12-13

Ferritin nanoparticle compositions and methods to modulate cell activity

 #190
20180344749
2018-12-06

CONTROLLED RELEASE FORMULATIONS OF SALICLATE-RELEASING ACTIVES

 #191
20180344656
2018-12-06

DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS

 #192
20180344647
2018-12-06

PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF

 #193
20180325855
2018-11-15

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #194
20180325822
2018-11-15

Biochars for use with animals

 #195
20180289667
2018-10-11

Anti-methanogenic lovastatin analogs or derivatives and uses thereof

 #196
20180263947
2018-09-20

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #197
20180228866
2018-08-16

COMPOSITIONS

 #198
20180221465
2018-08-09

Anti-malaria compositions and methods

 #199
20180221307
2018-08-09

TAMPER RESISTANT DOSAGE FORM WITH BIMODAL RELEASE PROFILE MANUFACTURED BY CO-EXTRUSION

 #200
20180200249
2018-07-19

Temozolomide powder formulation

 #201
20180199595
2018-07-19

Zilpaterol animal premix formulation

 #202
20180185296
2018-07-05

Biodegradable Microcapsules Containing Filling Material

 #203
20180161280
2018-06-14

PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS

 #204
20180133159
2018-05-17

Methods and materials for delivering agents to liver tissue

 #205
20180104237
2018-04-19

Systems and methods for treating an opioid-induced adverse pharmacodynamic response

 #206
20180104191
2018-04-19

POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS

 #207
20180098957
2018-04-12

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #208
20180071318
2018-03-15

Vitamin D receptor/SMAD genomic circuit gates fibrotic response

 #209
20180064675
2018-03-08

ACTIVE FORMULATION FOR USE IN FEED PRODUCTS

 #210
20180050032
2018-02-22

Temozolomide powder formulation

 #211
20180050005
2018-02-22

Concentrated Solution of 17-Hydroxydocosahexaenoic Acid

 #212
20180042989
2018-02-15

IMMUNOMODULATORY COMPOSITIONS

 #213
20180042854
2018-02-15

Methods of treating attention deficit hyperactivity disorder

 #214
20180028483
2018-02-01

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

 #215
20180028447
2018-02-01

Development of curcumin and piperine loaded double-layered biopolymer based nano delivery systems by using electrospray / coating method

 #216
20180021258
2018-01-25

Multivalent nanoparticle-based vaccines

 #217
20180008544
2018-01-11

Controlled release formulations

 #218
20180000954
2018-01-04

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #219
20180000130
2018-01-04

Feed ingredients comprising lysed microbial cells

 #220
20170360709
2017-12-21

Carrier-free nanoparticles

 #221
20170333365
2017-11-23

CORE-SHELL PARTICLE FORMULATION FOR DELIVERING MULTIPLE THERAPEUTIC AGENTS

 #222
20170318839
2017-11-09

Compositions of particulate coformulation

 #223
20170304394
2017-10-26

Orally disintegrating solid pharmaceutical dosage unit containing a partus control substance

 #224
20170281549
2017-10-05

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

 #225
20170281545
2017-10-05

Immunomodulation using spores and pollen grains

 #226
20170275196
2017-09-28

POROUS AND NON-POROUS BODIES

 #227
20170274088
2017-09-28

Modified release formulations containing drug-ion exchange resin complexes

 #228
20170266122
2017-09-21

Method of making particles for use in a pharmaceutical composition

 #229
20170258725
2017-09-14

Formulation comprising particles containing a water-swellable or water-soluble polymeric component and a lipid component

 #230
20170239285
2017-08-24

DEVELOPMENT OF MAGNETIC-MICRO PARTICLES THAT PROVIDE CONTROLLED GLYCOSAMINOGLYCAN (GAG) RELEASE AND THE INTRAVESICAL USAGE OF IT IN INTERSTITIAL CYSTITIS

 #231
20170231988
2017-08-17

Pharmaceutical composition of rosuvastatin calcium

 #232
20170231940
2017-08-17

Multiparticulate L-Carnitine And Nootropic Compositions And Related Methods

 #233
20170209491
2017-07-27

Process for obtaining fluoride-doped citrate-coated amorphous calcium phosphate nanoparticles

 #234
20170196812
2017-07-13

Biochars for use with animals

 #235
20170196811
2017-07-13

CORE-SHELL PARTICLE FORMULATION FOR DELIVERING MULTIPLE THERAPEUTIC AGENTS

 #236
20170172947
2017-06-22

Pharmaceutical compositions for inhalation

 #237
20170135956
2017-05-18

Fish feed compositions containing a neonicotinoid for preventing and treating parasite infections

 #238
20170119803
2017-05-04

Nanoparticle formulations for delivering multiple therapeutic agents

 #239
20170112791
2017-04-27

SOLID FORMULATIONS CONTAINING OMEGA-3 AND RESVERATROL

 #240
20170112770
2017-04-27

Controlled release delivery device comprising an organosol coat

 #241
20170106102
2017-04-20

Nanoparticles for diagnosis and treatment of tumors

 #242
20170100487
2017-04-13

Modified release formulations containing drug-ion exchange resin complexes

 #243
20170095435
2017-04-06

AGENT FOR THE TREATMENT AND PREVENTION OF AUTISM SPECTRUM DISORDERS

 #244
20170087115
2017-03-30

Composition preventing necrotic enteritis in galloanserans

 #245
20170079921
2017-03-23

Methods of preparing oral controlled release formulations

 #246
20170071926
2017-03-16

Methods of treating attention deficit hyperactivity disorder

 #247
20170071865
2017-03-16

Active agent-containing microcapsules

 #248
20160346391
2016-12-01

Compositions and methods to modulate cell activity

 #249
20160346308
2016-12-01

Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infection

 #250
20160346212
2016-12-01

Method of drug formulation

 #251
20160338984
2016-11-24

Particle formulations of all-trans retinoic acid and transforming growth factor beta for the treatment of type 1 diabetes mellitus

 #252
20160324835
2016-11-10

METHODS FOR IMPROVING MUSCLE STRENGTH

 #253
20160317575
2016-11-03

Anti-inflammatory compounds in combination with hydrogen for the treatment of inflammation

 #254
20160317455
2016-11-03

Nested particles and the use thereof for coordinated delvery of active agents

 #255
20160310449
2016-10-27

Modified release formulations containing drug-ion exchange resin complexes

 #256
20160310438
2016-10-27

Modified release formulations containing drug - ion exchange resin complexes

 #257
20160296471
2016-10-13

Surface binding of nanoparticle based drug delivery to tissue

 #258
20160263033
2016-09-15

LIPID COMPOSITION FOR IMPROVING BODY COMPOSITION DURING CATCH-UP GROWTH

 #259
20160243046
2016-08-25

Method of making particles for use in a pharmaceutical composition

 #260
20160235776
2016-08-18

SUSTAINED-RELEASE COMPOSITIONS COMPRISING TOPIRAMATE AND AN ALKALIZER

 #261
20160206665
2016-07-21

Encapsulated cells for hormone replacement therapy

 #262
20160206654
2016-07-21

METHODS AND FEED SUPPLEMENTS FOR LIVESTOCK

 #263
20160199378
2016-07-14

Layered sustained-release microbeads and methods of making the same

 #264
20160166659
2016-06-16

Digestive enzyme composition suitable for enteral administration

 #265
20160158373
2016-06-09

Modified release formulations containing drug-ion exchange resin complexes

 #266
20160151404
2016-06-02

Nucleic acid particles, methods and use thereof

 #267
20160151351
2016-06-02

NON-ABUSABLE PHARMACEUTICAL COMPOSITION COMPRISING OPIOIDS

 #268
20160151287
2016-06-02

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

 #269
20160120813
2016-05-05

Functional polymer film-coated particle having high drug content, tablet containing same, and methods for production thereof

 #270
20160113913
2016-04-28

CONTROLLED-RELEASE DRUG FORMULATION

 #271
20160113880
2016-04-28

Once Daily Formulations of Tetracyclines

 #272
20160106762
2016-04-21

Vitamin D receptor/SMAD genomic circuit gates fibrotic response

 #273
20160101060
2016-04-14

Controlled release doxycycline

 #274
20160101052
2016-04-14

Controlled release doxycycline

 #275
20160081933
2016-03-24

PROCESS FOR STABILIZING THE DRUG RELEASE PROFILES OF POLYMER FILM COATED PHARMACEUTICAL COMPOSITIONS

 #276
20160076086
2016-03-17

Nano-plasmonic molecular probes and methods of use

 #277
20160074397
2016-03-17

COMPOSITION FOR REDUCING FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

 #278
20160060279
2016-03-03

Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications

 #279
20160045576
2016-02-18

Enzyme delivery systems and methods of preparation and use

 #280
20160045441
2016-02-18

Pharmaceutical Compositions Comprising Everolimus

 #281
20160015694
2016-01-21

COMPOSITION FOR REDUCING THE FREQUENCY OF URINATION, METHOD OF MAKING AND USE THEREOF

 #282
20160008335
2016-01-14

Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters

 #283
20150366908
2015-12-24

SILICA-COATED CALCIUM SALT COMPOSITIONS

 #284
20150366241
2015-12-24

COMPOSITIONS OF PARTICULATE COFORMULATION

 #285
20150359744
2015-12-17

Increasing drug affinity for crystalline microparticle surfaces

 #286
20150352145
2015-12-10

Method and System for Treatment of Damaged Biological Tissue

 #287
20150352050
2015-12-10

BIODEGRADABLE MICROBEADS WITH IMPROVED ANTICANCER DRUG ADSORPTIVITY, CONTAINING ALBUMIN AND DEXTRAN SULFATE, AND PREPARATION METHOD THEREFOR

 #288
20150335589
2015-11-26

Enzyme delivery systems and methods of preparation and use

 #289
20150313850
2015-11-05

Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

 #290
20150297520
2015-10-22

MEDICAMENT-CONTAINING HOLLOW PARTICLE

 #291
20150290234
2015-10-15

TARGETED INTRACELLULAR DELIVERY OF ANTIVIRAL AGENTS

 #292
20150290147
2015-10-15

PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR COLONIC ABOSORPTION

 #293
20150283170
2015-10-08

COATED PHARMACEUTICAL COMPOSITIONS

 #294
20150258029
2015-09-17

Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms

 #295
20150231077
2015-08-20

AMINE PASSIVATED NANOPARTICLES FOR CANCER TREATMENT AND IMAGING

 #296
20150216858
2015-08-06

Systems and methods for treating an opioid-induced adverse pharmacodynamic response

 #297
20150209305
2015-07-30

Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics

 #298
20150209288
2015-07-30

Core-shell particle formulation for delivering multiple therapeutic agents

 #299
20150202155
2015-07-23

Cross-linked polymer particles

 #300
20150196554
2015-07-16

Systems and methods for treating an opioid-induced adverse pharmacodynamic response